These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

145 related articles for article (PubMed ID: 28540403)

  • 21. Differences in miRNA expression in early stage lung adenocarcinomas that did and did not relapse.
    Edmonds MD; Eischen CM
    PLoS One; 2014; 9(7):e101802. PubMed ID: 25028925
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Plasma circulating microRNA-944 and microRNA-3662 as potential histologic type-specific early lung cancer biomarkers.
    Powrózek T; Krawczyk P; Kowalski DM; Winiarczyk K; Olszyna-Serementa M; Milanowski J
    Transl Res; 2015 Oct; 166(4):315-23. PubMed ID: 26079400
    [TBL] [Abstract][Full Text] [Related]  

  • 23. miRNA-197 and miRNA-184 are associated with brain metastasis in EGFR-mutant lung cancers.
    Remon J; Alvarez-Berdugo D; Majem M; Moran T; Reguart N; Lianes P
    Clin Transl Oncol; 2016 Feb; 18(2):153-9. PubMed ID: 26199015
    [TBL] [Abstract][Full Text] [Related]  

  • 24. miR-126-3p and miR-451a correlate with clinicopathological features of lung adenocarcinoma: The underlying molecular mechanisms.
    Chen Q; Hu H; Jiao D; Yan J; Xu W; Tang X; Chen J; Wang J
    Oncol Rep; 2016 Aug; 36(2):909-17. PubMed ID: 27277197
    [TBL] [Abstract][Full Text] [Related]  

  • 25. miR-1254 and miR-574-5p: serum-based microRNA biomarkers for early-stage non-small cell lung cancer.
    Foss KM; Sima C; Ugolini D; Neri M; Allen KE; Weiss GJ
    J Thorac Oncol; 2011 Mar; 6(3):482-8. PubMed ID: 21258252
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Two lung development-related microRNAs, miR-134 and miR-187, are differentially expressed in lung tumors.
    Mirzadeh Azad F; Naeli P; Malakootian M; Baradaran A; Tavallaei M; Ghanei M; Mowla SJ
    Gene; 2016 Feb; 577(2):221-6. PubMed ID: 26642897
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Aberrant miR-181b-5p and miR-486-5p expression in serum and tissue of non-small cell lung cancer.
    Tian F; Shen Y; Chen Z; Li R; Lu J; Ge Q
    Gene; 2016 Oct; 591(2):338-43. PubMed ID: 27291819
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Clinical value of miR-198-5p in lung squamous cell carcinoma assessed using microarray and RT-qPCR.
    Liang YY; Huang JC; Tang RX; Chen WJ; Chen P; Cen WL; Shi K; Gao L; Gao X; Liu AG; Peng XT; Chen G; Huang SN; Fang YY; Gu YY
    World J Surg Oncol; 2018 Feb; 16(1):22. PubMed ID: 29394946
    [TBL] [Abstract][Full Text] [Related]  

  • 29. A MicroRNA cluster at 14q32 drives aggressive lung adenocarcinoma.
    Nadal E; Zhong J; Lin J; Reddy RM; Ramnath N; Orringer MB; Chang AC; Beer DG; Chen G
    Clin Cancer Res; 2014 Jun; 20(12):3107-17. PubMed ID: 24833665
    [TBL] [Abstract][Full Text] [Related]  

  • 30. A transcriptional miRNA-gene network associated with lung adenocarcinoma metastasis based on the TCGA database.
    Wang Y; Han R; Chen Z; Fu M; Kang J; Li K; Li L; Chen H; He Y
    Oncol Rep; 2016 Apr; 35(4):2257-69. PubMed ID: 26781266
    [TBL] [Abstract][Full Text] [Related]  

  • 31. FAM83B is a novel biomarker for diagnosis and prognosis of lung squamous cell carcinoma.
    Okabe N; Ezaki J; Yamaura T; Muto S; Osugi J; Tamura H; Imai J; Ito E; Yanagisawa Y; Honma R; Gotoh M; Watanabe S; Waguri S; Suzuki H
    Int J Oncol; 2015 Mar; 46(3):999-1006. PubMed ID: 25586059
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Utility of 10 immunohistochemical markers including novel markers (desmocollin-3, glypican 3, S100A2, S100A7, and Sox-2) for differential diagnosis of squamous cell carcinoma from adenocarcinoma of the Lung.
    Tsuta K; Tanabe Y; Yoshida A; Takahashi F; Maeshima AM; Asamura H; Tsuda H
    J Thorac Oncol; 2011 Jul; 6(7):1190-9. PubMed ID: 21623236
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Exosomal microRNA: a diagnostic marker for lung cancer.
    Rabinowits G; Gerçel-Taylor C; Day JM; Taylor DD; Kloecker GH
    Clin Lung Cancer; 2009 Jan; 10(1):42-6. PubMed ID: 19289371
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Rule discovery and distance separation to detect reliable miRNA biomarkers for the diagnosis of lung squamous cell carcinoma.
    Song R; Liu Q; Hutvagner G; Nguyen H; Ramamohanarao K; Wong L; Li J
    BMC Genomics; 2014; 15 Suppl 9(Suppl 9):S16. PubMed ID: 25521201
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Main histologic types of non-small-cell lung cancer differ in expression of prognosis-related genes.
    Skrzypski M; Dziadziuszko R; Jassem E; Szymanowska-Narloch A; Gulida G; Rzepko R; Biernat W; Taron M; Jelitto-Górska M; Marjański T; Rzyman W; Rosell R; Jassem J
    Clin Lung Cancer; 2013 Nov; 14(6):666-673.e2. PubMed ID: 23870818
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Analysis of tumor markers in the cytological fluid obtained from computed tomography-guided needle aspiration biopsy for the diagnosis of non-small cell lung cancer.
    Hong YJ; Hur J; Lee HJ; Nam JE; Kim YJ; Kim HS; Kim HY; Kim SK; Chang J; Kim JH; Chung KY; Choi BW; Choe KO
    J Thorac Oncol; 2011 Aug; 6(8):1330-5. PubMed ID: 21847061
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Diagnostic assay based on hsa-miR-205 expression distinguishes squamous from nonsquamous non-small-cell lung carcinoma.
    Lebanony D; Benjamin H; Gilad S; Ezagouri M; Dov A; Ashkenazi K; Gefen N; Izraeli S; Rechavi G; Pass H; Nonaka D; Li J; Spector Y; Rosenfeld N; Chajut A; Cohen D; Aharonov R; Mansukhani M
    J Clin Oncol; 2009 Apr; 27(12):2030-7. PubMed ID: 19273703
    [TBL] [Abstract][Full Text] [Related]  

  • 38. A prediction model for distinguishing lung squamous cell carcinoma from adenocarcinoma.
    Li H; Jiang Z; Leng Q; Bai F; Wang J; Ding X; Li Y; Zhang X; Fang H; Yfantis HG; Xing L; Jiang F
    Oncotarget; 2017 Aug; 8(31):50704-50714. PubMed ID: 28881596
    [TBL] [Abstract][Full Text] [Related]  

  • 39. MicroRNA profiling in lung cancer reveals new molecular markers for diagnosis.
    Solomides CC; Evans BJ; Navenot JM; Vadigepalli R; Peiper SC; Wang ZX
    Acta Cytol; 2012; 56(6):645-54. PubMed ID: 23207443
    [TBL] [Abstract][Full Text] [Related]  

  • 40. DNA methylation mediated silencing of microRNA-145 is a potential prognostic marker in patients with lung adenocarcinoma.
    Xia W; Chen Q; Wang J; Mao Q; Dong G; Shi R; Zheng Y; Xu L; Jiang F
    Sci Rep; 2015 Nov; 5():16901. PubMed ID: 26582602
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.